MCK Q3 2025 Earnings — McKesson Corporation Revenue & Financial Results | Market Cap Arena

MCKMcKesson Corporation

$115B

Q3 2025 Earnings

Healthcare Medical - Distribution

Income Statement

Revenue

$95.3B+17.8% YoY

Gross Profit

$3.2B3.4% margin

Operating Income

$1.3B1.4% margin

Net Income

$879M0.9% margin

EPS (Diluted)

$6.94

QoQ Revenue Growth

+1.8%

Cash Flow

Operating Cash Flow

-$2.4B

Free Cash Flow

-$2.6B

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$71.1B

Total Liabilities

$73.8B

Stockholders' Equity

-$3.1B

Cash & Equivalents

$1.1B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$95.3B	$80.9B	+17.8%
Gross Profit	$3.2B	$3.0B	+6.2%
Operating Income	$1.3B	$623M	+106.6%
Net Income	$879M	$589M	+49.2%

Revenue Segments

U.S. Pharmaceutical Segment

$87.1B91%

International Segment

$3.9B4%

Medical-Surgical Solutions Segment

$2.9B3%

Prescription Technology Solutions

$1.4B1%